Restart Life Sciences Corp.
NMLSF
$0.06
$0.0111.07%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.71% | -75.57% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.78% | -75.70% | |||
| Operating Income | -7.78% | 75.70% | |||
| Income Before Tax | -4.15% | 74.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.15% | 74.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.15% | 74.22% | |||
| EBIT | -7.78% | 75.70% | |||
| EBITDA | -7.71% | 75.75% | |||
| EPS Basic | 2.27% | 79.34% | |||
| Normalized Basic EPS | 0.00% | 80.19% | |||
| EPS Diluted | -1.39% | 66.20% | |||
| Normalized Diluted EPS | 0.00% | 80.19% | |||
| Average Basic Shares Outstanding | 6.84% | 25.67% | |||
| Average Diluted Shares Outstanding | 6.84% | 25.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||